The content is available as a PDF (253.6 KB).
. 2020 Aug 10:jiaa510. doi: 10.1093/infdis/jiaa510
Response to Rabelo-da-Ponte
Qing-Lei Zeng
1,#,✉, Zu-Jiang Yu
1,#, Fanpu Ji
2
Qing-Lei Zeng
1
Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China
Find articles by Qing-Lei Zeng
Zu-Jiang Yu
1
Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China
Find articles by Zu-Jiang Yu
Fanpu Ji
2
Department of Infectious Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province, China
Find articles by Fanpu Ji
1
Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China
2
Department of Infectious Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province, China
✉
Correspondence: Qing-Lei Zeng, The Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, No.1, Eastern Jianshe Road, Zhengzhou 450052, Henan Province, China. E-mail addresses: zengqinglei2009@163.com.
#
These authors contributed equally to this article.
Received 2020 Aug 2.
Keywords: Clinical outcome, Convalescent plasma therapy, Coronavirus disease 2019 (COVID-19)
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7454689 PMID: 32777045